- Home
- MKDW vs CYCC Comparison
MKDW vs CYCC Comparison
Compare MKDW & CYCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKDW
- CYCC
- Stock Information
- Founded
- MKDW 2006
- CYCC 1992
- Country
- MKDW Taiwan
- CYCC Malaysia
- Employees
- MKDW N/A
- CYCC N/A
- Industry
- MKDW
- CYCC Biotechnology: Pharmaceutical Preparations
- Sector
- MKDW
- CYCC Health Care
- Exchange
- MKDW NYSE
- CYCC Nasdaq
- Market Cap
- MKDW 40.2M
- CYCC 47.6M
- IPO Year
- MKDW N/A
- CYCC N/A
- Fundamental
- Price
- MKDW $0.31
- CYCC $2.32
- Analyst Decision
- MKDW
- CYCC Strong Buy
- Analyst Count
- MKDW 0
- CYCC 1
- Target Price
- MKDW N/A
- CYCC $11.00
- AVG Volume (30 Days)
- MKDW 2.7M
- CYCC 491.9K
- Earning Date
- MKDW 12-31-2024
- CYCC 05-20-2025
- Dividend Yield
- MKDW N/A
- CYCC 6.55%
- EPS Growth
- MKDW N/A
- CYCC N/A
- EPS
- MKDW N/A
- CYCC N/A
- Revenue
- MKDW $3,670,722.00
- CYCC $43,000.00
- Revenue This Year
- MKDW N/A
- CYCC $137.21
- Revenue Next Year
- MKDW N/A
- CYCC N/A
- P/E Ratio
- MKDW N/A
- CYCC N/A
- Revenue Growth
- MKDW 16.40
- CYCC N/A
- 52 Week Low
- MKDW $0.17
- CYCC $0.17
- 52 Week High
- MKDW $16.00
- CYCC $4.41
- Technical
- Relative Strength Index (RSI)
- MKDW N/A
- CYCC 33.91
- Support Level
- MKDW N/A
- CYCC $4.48
- Resistance Level
- MKDW N/A
- CYCC $5.92
- Average True Range (ATR)
- MKDW 0.00
- CYCC 1.23
- MACD
- MKDW 0.00
- CYCC -0.19
- Stochastic Oscillator
- MKDW 0.00
- CYCC 2.44
About MKDW MKDWELL TECH INC
MKDWell Tech Inc is a company engaged in supplying automotive electronics for passenger cars, modified commercial vehicles, camper vans and logistics vehicles. Its business coverage extends across the spectrum of research and development, design, production and sales of automotive electronic products. The main products are intelligent camper vans control systems, LiDAR sensors, intelligent container control systems for logistics vehicles, vehicle seat control system, and it provide customers with ODM and OEM customized services.
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib.